Invention Grant
US08765796B2 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide
有权
用于口服递送胰高血糖素样肽（GLP-1）化合物或黑皮质素-4受体（MC4）激动剂肽的化合物，方法和制剂
- Patent Title: Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide
- Patent Title (中): 用于口服递送胰高血糖素样肽（GLP-1）化合物或黑皮质素-4受体（MC4）激动剂肽的化合物，方法和制剂
-
Application No.: US13971680Application Date: 2013-08-20
-
Publication No.: US08765796B2Publication Date: 2014-07-01
- Inventor: Robert J. Herr , Louis N. Jungheim , John M. McGill , Kenneth J. Thrasher , Muralikrishna Valluri
- Applicant: Emisphere Technologies, Inc.
- Applicant Address: US NJ Roseland
- Assignee: Emisphere Technologies, Inc.
- Current Assignee: Emisphere Technologies, Inc.
- Current Assignee Address: US NJ Roseland
- Agency: Blank Rome LLP
- Main IPC: A61K31/421
- IPC: A61K31/421 ; C07D263/30
Abstract:
The present invention relates to novel compounds, methods, and formulations useful for the oral delivery of a GLP-1 compound or an MC4 agonist peptide.
Public/Granted literature
Information query
IPC分类:
